Superoxide anion-dependent Raf/MEK/ERK activation by peroxisome proliferator activated receptor γ agonists 15-deoxy-Δ12,14-prostaglandin J2, ciglitazone, and GW1929

Experimental Cell Research

Volumn 277, Issue 2, 2002, Pages 192-200

  Huang, Wan Chen ^a   Chio, Chung Ching ^b   Chi, Kwan Hwa ^c   Wu, Hsiao Mei ^a   Lin, Wan Wan ^a  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^b Chi Mei Foundation Hospital   (Taiwan)

^c TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

Author keywords

15d PGJ2; C2C12; Ciglitazone; ERK; GW1929; PPAR ; Ras; ROS; Superoxide anion

Indexed keywords

15 DEOXY DELTA12,14 PROSTAGLANDIN J2; 2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 2 [1 (3 AMIDINOTHIOPROPYL) 1H INDOL 3 YL] 3 (1 METHYL 1H INDOL 3 YL)MALEIMIDE; 2 [1 (3 DIMETHYLAMINOPROPYL) 3 INDOLYL] 3 (3 INDOLYL)MALEIMIDE; 2 [2 OXO 2 [[(3,7,11 TRIMETHYL 2,6,10 DODECATRIENYL)OXY]AMINO]ETHYL]PHOSPHONIC ACID; BISPHENOL A DIGLYCIDIL ETHER; CIGLITAZONE; ETHER DERIVATIVE; GLUTATHIONE; MITOGEN ACTIVATED PROTEIN KINASE 1; N (2 BENZOYLPHENYL) O [2 (METHYL 2 PYRIDINYLAMINO)ETHYL]TYROSINE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR AGONIST; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA 2; PHOSPHINIC ACID DERIVATIVE; RAF PROTEIN; SUPEROXIDE; UNCLASSIFIED DRUG; WORTMANNIN;

ANIMAL CELL; ARTICLE; CHEMOLUMINESCENCE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DNA BINDING; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; DRUG POTENCY; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME ASSAY; MOUSE; MYOBLAST; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION;

MURINAE;

EID: 0036314868     PISSN: 00144827     EISSN: None     Source Type: Journal    
DOI: 10.1006/excr.2002.5546     Document Type: Article

References (45)

1. Activation of a member of the steroid receptor superfamily by peroxisome proliferators
2. The RXR heterodimers and orphan receptors
3. Peroxisome proliferator-activated receptors: A nuclear receptor signalling pathway in lipid physiology
4. Central role of peroxisome proliferator-activated receptors in the action of peroxisome proliferators
5. Targeted disruption of the alpha isoform of the peroxisome proliferator-activated receptor gene in mice results in abolishment of the pleiotropic effects of peroxisome proliferators
6. Peroxisome proliferator-activated receptors: Transcriptional regulators of adipogenesis, lipid metabolism and more
7. Transcriptional regulation of gene expression during adipocyte differentiation
8. PPAR-γ agonists inhibit production of monocyte inflammatory cytokines
9. The peroxisome proliferator-activated receptor-γ is a negative regulator of macrophage activation
10. 2 is a ligand for the adipocyte determination factor PPARγ
11. 2 metabolite binds peroxisome proliferator-activated receptor γ promotes adipocyte differentiation
12. Peroxisomal enzyme induction uncoupled from enhanced DNA synthesis in putative preneo-plastic liver foci of rats treated with a single dose of the peroxisome proliferator nafenopin
13. Mechanistically-based human hazard assessment of peroxisome proliferator-induced hepatocarcinogenesis
14. Peroxisome proliferators activate extracellular signal-regulated kinases in immortalized mouse liver cells
15. 2 in activated murine macrophages
16. Anti-inflammatory cyclopentenone prostaglandins are direct inhibitors of IκB kinase
17. 2 inhibition of NF-κB-DNA binding through covalent modification of the p50 subunit
18. 1 arrest and differentiation marker expression in vascular smooth muscle cells
19. 2
20. 2 inhibits the β2 intergrin-dependent oxidative burst: Involvement of a mechanism distinct from peroxime proliferator-activated receptor γ ligation
21. The ins and outs of Raf kinases
22. Ras recruits Raf-1 to the plasma membrane for activation by tyrosine phosphorylation
23. Isotype-specific functions of Raf kinases
24. The peroxisome proliferator-activated receptor α is a phosphoprotein: Regulation by insulin
25. Inhibition of adipogenesis through MAP kinase-mediated phosphorylation of PPARgamma
26. Transcriptional activation by peroxisome proliferator-activated receptor γ is inhibited by phosphorylation at a consensus mitogen-activated protein kinase site
27. Prostaglandins promote and block adipogenesis through opposite effects on peroxisome proliferator-activated receptor gamma
28. MAP kinase kinase from rabbit skeletal muscle: A novel dual specificity enzyme showing homology to yeast protein kinases involved in pheromone-dependent signal transduction
29. Linkage of G protein-coupled receptors to the MAPK signalling pathway through PI 3-kinase gamma
30. 2 receptors stimulate mitogen-activated protein kinase in human embryonic kidney-293 cells
31. Degradation of the peroxisome proliferator-activated is linked to ligand-dependent activation
32. Stimulation of adipogenesis in fibroblasts by PPAR gamma 2, a lipid-activated transcription factor
33. A synthetic antagonist for the peroxisome proliferator activated receptor γ inhibits adipocyte differentiation
34. 2: Role in cell survival following oxidant injury
35. Oxidant stress incites spreading of macrophages via extracellular signal-regulated protein kinases and p38 mitogen-activated protein kinase
36. Potential new treatments for type 2 diabetes
37. New perspectives into the molecular pathogenesis and treatment of type 2 diabetes
38. A novel N-aryl tyrosine activator of peroxisome proliferator-activated receptor-γ reverses diabetic phenotype of the Zucker diabetic fatty rat
39. PPARγ agonists: Therapeutic role in diabetes, inflammation and cancer
40. AH6809, a prostaglandin DP-receptor blocking drug on human platelets
41. Ras activation of the Raf kinase: Tyrosine kinase recruitment of the MAP kinase cascade
42. Interferon gamma activation of Raf-1 is Jak1-dependent and p21ras-independent
43. Contribution of cyclopentenone prostaglandins to the resolution of inflammation through the potentiation of apoptosis in activated macrophages
44. Peroxisome proliferator-activated receptor-γ-independent inhibition of macrophage activation by the non-thiazolidinedione agonist L-796,449
45. Insulin and mitogen-activated protein kinase-mediated phosphorylation and activation of peroxisome proliferator-activated receptor gamma